Moderna Inc

NAS:MRNAHealthcareCBOE:SPESGNASDAQ:NBI

$226.89+4.07%At closeAt close · Tue 20 Oct · ≈ AED 833.25 · Market cap $90.58B · Next earnings Thu 5 Nov · Extended $227.90 +0.45%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	95.1%	85.2%	71.3%	31.5%	54.2%	55.3%	—	—
Operating margin	−95.0%	75.0%	49.9%	−61.9%	−123.3%	−158.1%	−158.1%	+0.0 pts
Net margin	−93.0%	68.8%	44.3%	−68.8%	−111.3%	−145.2%	−145.2%	+0.0 pts
EBITDA margin	−87.6%	76.3%	52.7%	−47.9%	−106.1%	−131.3%	—	—
Return on equity	−29.2%	86.3%	43.7%	−34.0%	−32.7%	−32.6%	−32.6%	+0.0 pts
Return on assets	−10.2%	49.5%	32.3%	−25.6%	−25.2%	−22.9%	−22.9%	+0.0 pts
Return on capital employed	−25.9%	85.6%	45.0%	−27.5%	−33.1%	−29.7%	—	—
Debt / equity	0.1×	0.1×	0.1×	0.1×	0.1×	0.2×	0.2×	+0.0%
Debt / assets	3.2%	3.7%	4.6%	6.7%	5.3%	15.5%	—	—
Interest coverage	−77.2×	738.7×	324.8×	−111.6×	−164.4×	−307.4×	—	—
Current ratio	1.4×	1.8×	2.7×	3.4×	3.7×	3.3×	3.3×	+0.0%
Quick ratio	1.4×	1.6×	2.5×	3.4×	3.6×	3.2×	—	—
Cash ratio	0.6×	0.8×	0.7×	1.0×	0.9×	1.3×	1.3×	+0.0%
Asset turnover	0.1×	0.7×	0.7×	0.4×	0.2×	0.2×	—	—
Inventory turnover	0.8×	1.8×	5.7×	23.2×	12.5×	5.7×	—	—
Receivables turnover	0.6×	5.3×	11.2×	6.3×	5.4×	6.8×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—